Skip to main content
. 2022 Jul 7;159(1):65–79. doi: 10.1007/s11060-022-04044-1

Table 2.

Extent of change in cognitive performance between baseline and follow-up neuropsychological assessment represented by mean differences (Mdiff) of percentile ranks (T2-T1; a score > 0 indicates a numerical improvement of cognitive performance over time), separated for dichotomized treatment groups (without radiotherapy [RT-] vs. with radiotherapy [RT+] and without chemotherapy [ChT-] vs. with chemotherapy [ChT+])

RT-  (n = 52) RT+   (n = 34) ANOVA ChT-  (n = 41) ChT+  (n = 45) ANOVA
Mdiff (95% CI) Mdiff (95% CI) F-value df p-value Mdiff (95% CI) Mdiff (95% CI) F-value df p-value
Short-term memory 15.2 (7.2–23.3) 3.6 (-6.5–13.7) 3.34 1,84 0.071 10.1 (0.2–20.1) 11.1 (2.8–19.3) 0.02 1,84 0.885
Working memory 20.3 (6.4–34.2) 15.5 (2.5–28.4) 0.23 1,83 0.630 14.1 (-1.2–29.4) 22.3 (9.5–35.1) 0.71 1,83 0.403
Simple reaction time 8.3 (-0.6–17.3) 20.0 (10.3–29.6) 2.98 1,83 0.088 11.6 (1.3–22.0) 14.0 (5.2–22.8) 0.13 1,83 0.724
Selective attention 19.3 (11.3–27.3) 26.4 (13.5–39.3) 1.00 1,81 0.320 19.1 (9.1–29.1) 24.5 (14.8–34.1) 0.60 1,81 0.440
Inhibition 15.2 (6.2–24.2) 19.9 (7.6–32.2) 0.41 1,82 0.523 16.5 (5.1–27.8) 17.4 (8.0–26.8) 0.02 1,82 0.897
Verbal memory 14.8 (7.0–22.5) 6.1 (-0.8–13.0) 2.40 1,82 0.125 13.6 (5.1–22.0) 9.4 (2.1–16.7) 0.58 1,82 0.449
Figural memory 21.8 (14.8–28.9) 8.3 (-2.4–19.0) 4.95 1,76 0.029* a 17.1 (7.2–26.9) 15.1 (6.9–23.2) 0.10 1,76 0.752
Fluency 10.4 (1.6–19.1) 18.6 (6.7–30.5) 1.31 1,82 0.256 16.5 (6.3–26.7) 11.0 (1.1–20.8) 0.61 1,82 0.438

ANOVA test statistics illustrate differences in extent of cognitive change between RT- patients and RT+  patients and between ChT- patients and ChT+ patients, respectively. Asterisks indicate statistically significant group differences

CI confidence interval, df degree of freedom

a Non-irradiated patients show a significantly greater increase in figural memory performance than irradiated patients within two years after post-surgery baseline assessment

p < 0.05